This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://linked.opendata.cz/resource/drugbank/drug/DB04285/identifier/pdb/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04285/identifier/pubchem-compound/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB04285/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04285/identifier/drugbank/

Statements

Subject Item
n2:DB04285
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB04285 n8:DB04285
dcterms:title
{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid
adms:identifier
n10:21145368 n11:46508576 n12:DB04285 n13:P90
n3:IUPAC-Name
n4:271B4BF6-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4BFC-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4BFB-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4BF8-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4BF9-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4BFA-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4BF4-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4BF2-363D-11E5-9242-09173F13E4C5 n4:271B4BF5-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4BF3-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4C02-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4C03-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4BFD-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4BFE-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4C00-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4BFF-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4C01-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4C08-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4C0A-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4C0B-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4C07-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4C06-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4C09-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4BF7-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4C04-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4C05-363D-11E5-9242-09173F13E4C5